Table 2 Number of genes/mutations included in the final training dataset and testing dataset, and the actual number of resistant and susceptible mutations included in both training and test dataset.
Drug | Gene | Training set | Testing set | ||||
---|---|---|---|---|---|---|---|
Resistant | Susceptible | Total | Resistant | Susceptible | Total | ||
Rifampin | rpoB | 40 | 52 | 92 | 10 | 12 | 22 |
Isoniazid | InhA | 8 | 14 | 22 | 2 | 3 | 5 |
katG | 108 | 92 | 201 | 27 | 23 | 50 | |
Pyrazinamide | pncA | 112 | 81 | 193 | 27 | 21 | 48 |
Fluoroquinolones | gyrA | 25 | 33 | 58 | 6 | 8 | 14 |
gyrB | 23 | 17 | 40 | 5 | 4 | 9 |